Europe Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Non-Melanoma and Melanoma), By Test Type (Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others), ByEnd-use, By Country and Growth Forecast, 2024 - 2031

The Europe Skin Cancer Diagnostics Market would witness market growth of 5.0% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Skin Cancer Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $895.1 million by 2031. The UK market is exhibiting a CAGR of 4.1% during (2024 - 2031). Additionally, The France market would exhibit a CAGR of 5.9% during (2024 - 2031).

The rising incidence of skin cancer is a central driver of the market. The direct DNA damage that UV radiation causes in skin cells is a well-established risk factor for skin cancer, which can result in malignant transformations. Demographic trends also significantly influence the growing demand for skin cancer diagnostics.

Additionally, Consequently, the aging population is more susceptible to both melanoma and non-melanoma skin cancers, necessitating more frequent and sophisticated diagnostic interventions.

The risk of developing skin cancer demonstrably increases with age. Cumulative sun exposure throughout a lifetime plays a major role. As the European population ages, a greater number of individuals are inherently more susceptible to skin cancer. The demand for skin cancer diagnostics in the United Kingdom is increasing significantly due to an aging population. Non-melanoma skin cancer incidence rates are projected to rise by 14% from 2023-2025 to 2038-2040, reaching 310 cases per 100,000 people annually by 2038-2040.

Free Valuable Insights: The Global Skin Cancer Diagnostics Market will Hit USD 12.8 Billion by 2031, at a CAGR of 5.3%

Based on Type, the market is segmented into Non-Melanoma and Melanoma. Based on Test Type, the market is segmented into Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others. Based on End-use, the market is segmented into Hospital & Clinics, Laboratories, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Castle Biosciences, Inc.
• Bausch Health Companies, Inc. (DermTech, Inc.)
• Canfield Scientific, Inc.
• DermaSensor, Inc.
• F.Hoffmann-La Roche Ltd.
• NeoGenomics, Inc.
• Quest Diagnostics Incorporated.
• Digital Diagnostics, Inc. (3Derm Systems, Inc.)
• FotoFinder Systems GmbH
• Veriskin Inc

Europe Skin Cancer Diagnostics Market Report Segmentation

By Type

• Non-Melanoma
• Melanoma

By Test Type

• Skin Biopsy
• Imaging Tests
• Dermatoscopy
• Lymph Node Biopsy
• Others

By End-use

• Hospital & Clinics
• Laboratories
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Skin Cancer Diagnostics Market, by Type
1.4.2 Europe Skin Cancer Diagnostics Market, by Test Type
1.4.3 Europe Skin Cancer Diagnostics Market, by End-use
1.4.4 Europe Skin Cancer Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Skin Cancer Diagnostics Market by Type
4.1 Europe Non-Melanoma Market by Country
4.2 Europe Melanoma Market by Country

Chapter 5. Europe Skin Cancer Diagnostics Market by Test Type
5.1 Europe Skin Biopsy Market by Country
5.2 Europe Imaging Tests Market by Country
5.3 Europe Dermatoscopy Market by Country
5.4 Europe Lymph Node Biopsy Market by Country
5.5 Europe Others Market by Country

Chapter 6. Europe Skin Cancer Diagnostics Market by End-use
6.1 Europe Hospital & Clinics Market by Country
6.2 Europe Laboratories Market by Country
6.3 Europe Others Market by Country

Chapter 7. Europe Skin Cancer Diagnostics Market by Country
7.1 Germany Skin Cancer Diagnostics Market
7.1.1 Germany Skin Cancer Diagnostics Market by Type
7.1.2 Germany Skin Cancer Diagnostics Market by Test Type
7.1.3 Germany Skin Cancer Diagnostics Market by End-use
7.2 UK Skin Cancer Diagnostics Market
7.2.1 UK Skin Cancer Diagnostics Market by Type
7.2.2 UK Skin Cancer Diagnostics Market by Test Type
7.2.3 UK Skin Cancer Diagnostics Market by End-use
7.3 France Skin Cancer Diagnostics Market
7.3.1 France Skin Cancer Diagnostics Market by Type
7.3.2 France Skin Cancer Diagnostics Market by Test Type
7.3.3 France Skin Cancer Diagnostics Market by End-use
7.4 Russia Skin Cancer Diagnostics Market
7.4.1 Russia Skin Cancer Diagnostics Market by Type
7.4.2 Russia Skin Cancer Diagnostics Market by Test Type
7.4.3 Russia Skin Cancer Diagnostics Market by End-use
7.5 Spain Skin Cancer Diagnostics Market
7.5.1 Spain Skin Cancer Diagnostics Market by Type
7.5.2 Spain Skin Cancer Diagnostics Market by Test Type
7.5.3 Spain Skin Cancer Diagnostics Market by End-use
7.6 Italy Skin Cancer Diagnostics Market
7.6.1 Italy Skin Cancer Diagnostics Market by Type
7.6.2 Italy Skin Cancer Diagnostics Market by Test Type
7.6.3 Italy Skin Cancer Diagnostics Market by End-use
7.7 Rest of Europe Skin Cancer Diagnostics Market
7.7.1 Rest of Europe Skin Cancer Diagnostics Market by Type
7.7.2 Rest of Europe Skin Cancer Diagnostics Market by Test Type
7.7.3 Rest of Europe Skin Cancer Diagnostics Market by End-use

Chapter 8. Company Profiles
8.1 Castle Biosciences, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.1.4.2 Acquisition and Mergers:
8.1.5 SWOT Analysis
8.2 Bausch Health Companies, Inc.(DermTech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Canfield Scientific, Inc.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 DermaSensor, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Neogenomics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Quest Diagnostics Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.7.4.2 Acquisition and Mergers:
8.7.5 SWOT Analysis
8.8 Digital Diagnostics, Inc.(3Derm Systems, Inc.)
8.8.1 Company Overview
8.9 FotoFinder Systems GmbH
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. VERISKIN INC.
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 Europe Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 Europe Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 Europe Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 4 Europe Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 5 Europe Non-Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Non-Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 10 Europe Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 11 Europe Skin Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe Skin Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe Imaging Tests Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Imaging Tests Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Dermatoscopy Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Dermatoscopy Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Lymph Node Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Lymph Node Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 20 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 21 Europe Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 22 Europe Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 23 Europe Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Skin Cancer Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Skin Cancer Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 31 Germany Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 32 Germany Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 33 Germany Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 34 Germany Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 35 Germany Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 36 Germany Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 37 Germany Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 38 Germany Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 39 UK Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 40 UK Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 41 UK Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 42 UK Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 43 UK Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 44 UK Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 45 UK Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 46 UK Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 47 France Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 48 France Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 49 France Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 50 France Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 51 France Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 52 France Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 53 France Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 54 France Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 55 Russia Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 56 Russia Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 57 Russia Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 58 Russia Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 59 Russia Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 60 Russia Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 61 Russia Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 62 Russia Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 63 Spain Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 64 Spain Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 65 Spain Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 66 Spain Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 67 Spain Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 68 Spain Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 69 Spain Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 70 Spain Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 71 Italy Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 72 Italy Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 73 Italy Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 74 Italy Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 75 Italy Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 76 Italy Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 77 Italy Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 78 Italy Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 79 Rest of Europe Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 80 Rest of Europe Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 81 Rest of Europe Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 82 Rest of Europe Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 83 Rest of Europe Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 84 Rest of Europe Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 85 Rest of Europe Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 86 Rest of Europe Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 87 Key Information – Castle Biosciences, Inc.
TABLE 88 key information – Bausch Health Companies, Inc.
TABLE 89 Key Information – Canfield Scientific, Inc.
TABLE 90 Key Information – Dermasensor, Inc.
TABLE 91 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 92 Key Information – neogenomics, inc.
TABLE 93 Key information – Quest Diagnostics Incorporated
TABLE 94 Key Information – Digital Diagnostics, Inc.
TABLE 95 Key Information – FotoFinder Systems GmbH
TABLE 96 Key Information – Veriskin Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Skin Cancer Diagnostics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Skin Cancer Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Skin Cancer Diagnostics Market
FIG 5 Europe Skin Cancer Diagnostics Market share by Type, 2023
FIG 6 Europe Skin Cancer Diagnostics Market share by Type, 2031
FIG 7 Europe Skin Cancer Diagnostics Market by Type, 2020 - 2031, USD Million
FIG 8 Europe Skin Cancer Diagnostics Market share by Test Type, 2023
FIG 9 Europe Skin Cancer Diagnostics Market share by Test Type, 2031
FIG 10 Europe Skin Cancer Diagnostics Market by Test Type, 2020 - 2031, USD Million
FIG 11 Europe Skin Cancer Diagnostics Market share by End-use, 2023
FIG 12 Europe Skin Cancer Diagnostics Market share by End-use, 2031
FIG 13 Europe Skin Cancer Diagnostics Market by End-use, 2020 - 2031, USD Million
FIG 14 Europe Skin Cancer Diagnostics Market share by Country, 2023
FIG 15 Europe Skin Cancer Diagnostics Market share by Country, 2031
FIG 16 Europe Skin Cancer Diagnostics Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT analysis: Castle Biosciences, Inc.
FIG 18 SWOT Analysis: Bausch Health Companies, Inc.
FIG 19 SWOT Analysis: Canfield Scientific, Inc.
FIG 20 SWOT analysis: DermaSensor, Inc.
FIG 21 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: Neogenomics, Inc.
FIG 23 SWOT Analysis: Quest Diagnostics Incorporated
FIG 24 SWOT Analysis: FotoFinder Systems GmbH
FIG 25 SWOT analysis: VERISKIN INC.